Elias, Gavin J. B. http://orcid.org/0000-0002-7495-550X
Germann, Jürgen http://orcid.org/0000-0003-0995-8226
Joel, Suresh E.
Li, Ningfei http://orcid.org/0000-0003-3315-3591
Horn, Andreas http://orcid.org/0000-0002-0695-6025
Boutet, Alexandre http://orcid.org/0000-0001-6942-5195
Lozano, Andres M.
Funding for this research was provided by:
RR Tasker Chair in Functional Neurosurgery at University Health Network; Tier 1 Canada Research Chair in Neuroscience
Gouvernement du Canada | Canadian Institutes of Health Research (164235, 471913)
Deutsche Forschungsgemeinschaft (424778381 – TRR 295)
Deutsches Zentrum für Luft- und Raumfahrt (DynaSti grant within the EU Joint Programme Neurodegenerative Disease Research, JPND)
Foundation for the National Institutes of Health (R01 13478451, 1R01NS127892-01, 2R01 MH113929)
New Venture Fund
Article History
Received: 25 September 2023
Accepted: 28 March 2024
First Online: 8 April 2024
Competing interests
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: A.M.L. is the co-founder of Functional Neuromodulation (a DBS-related company) and is a consultant for Boston Scientific, Medtronic, and Abbott (companies that produce DBS hardware). A.H. is a consultant for Functional Neuromodulation and reports lecture fees for Boston Scientific. S.E.J. is an employee at General Electric Global Research Center (a company that produces MRI devices). G.J.B.E., A.B., and A.M.L. have intellectual property in the field of DBS. There are no other potential conflicts of interest.